
IM-12
CAS No. 1129669-05-1
IM-12( IM 12 | IM12 )
Catalog No. M10456 CAS No. 1129669-05-1
IM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 43 | In Stock |
![]() ![]() |
10MG | 71 | In Stock |
![]() ![]() |
25MG | 141 | In Stock |
![]() ![]() |
50MG | 267 | In Stock |
![]() ![]() |
100MG | 444 | In Stock |
![]() ![]() |
500MG | 981 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameIM-12
-
NoteResearch use only, not for human use.
-
Brief DescriptionIM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling.
-
DescriptionIM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling; attenuates cell proliferation of ReNcell VM cells, induces nuclear accumulation of beta-catenin.
-
In VitroIM-12 inhibits GSK-3β in ReNcell VM cells, with I50 of 3.8 μM. IM-12 (3 μM) enhances the β-catenin amount, with no further effect at lower or higher concentration. IM-12 (3 μM) also attenuates the proliferation of ReNCell VM cells. IM-12 increases TCF-activity of ReNcell VM.
-
In Vivo——
-
SynonymsIM 12 | IM12
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3β
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number1129669-05-1
-
Formula Weight377.4115
-
Molecular FormulaC22H20FN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 54.9 mg/mL
-
SMILESFC(C=C1)=CC=C1CCNC(C2=O)=C(C(N2C)=O)C(C3=C(C=CC=C3)N4)=C4C
-
Chemical Name1H-Pyrrole-2,5-dione, 3-[[2-(4-fluorophenyl)ethyl]amino]-1-methyl-4-(2-methyl-1H-indol-3-yl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schm?le AC, et al. Bioorg Med Chem. 2010 Sep 15;18(18):6785-95.
molnova catalog



related products
-
5-Iodo-indirubin-3-m...
5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase (IC50s: 9, 20 and 25 nM).
-
WAY-352753
WAY-352753 is a GSK3B-glycogen synthase kinase-3 beta inhibitor.
-
GSK-3β inhibitor 11
GSK-3β inhibitor 11 (compound 21) is a potent glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 10.02 μM, demonstrating potential utility in neurodegenerative disease research .